Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brand/Generic Settlement Bill May Need Help From Authorized Generics Limits

Executive Summary

Supporters of legislation to curb settlements between brand and generic firms may consider modifying their proposal to include limits on authorized generics to garner more support

You may also be interested in...



FTC Wades Into Health Care Reform, But Authorized Generics Likely On Sidelines

For the third time in three weeks, the Federal Trade Commission has waded into the debate on health care reform with recommendations on competitive practices in the prescription drug market

FTC Wades Into Health Care Reform, But Authorized Generics Likely On Sidelines

For the third time in three weeks, the Federal Trade Commission has waded into the debate on health care reform with recommendations on competitive practices in the prescription drug market

Authorized Generic "Interim" Report From FTC Offers Little Legislative Guidance

FTC commissioners issue separate statements on a report that does not address the long-term effects of authorized generics.

Related Content

Topics

UsernamePublicRestriction

Register

PS050897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel